/

RMD

ResMed Inc.Pre-market

234.60+4.55 +1.98%USD

NYSE · as of Oct 12, 16:00 ET · 20m delay

Open

231.74

Prev close

230.05

Day range

230.08235.98

52-week range

180.27277.67

Volume

1.02M0.79×

Mkt cap

32.99B

P/E ttm

22.49

Fwd P/E

17.73

EPS ttm

10.43

Div yield

1.13%

Earnings

Oct 29, 2026

From 52w high

−15.51%

Price Chart

Yahoo Finance · delayed

RMDOct 12, 2026O 231.74H 235.98L 230.08C 234.60+4.55 (+1.98%)Vol 1.02M

SMA 50225.66
SMA 200225.15

1Y change −13.75% since Oct 10, 2025 close539 bars loadedTimes in America/New_YorkDraw from the left toolbar · click a drawing to edit · right-click for alerts and export

RMD ResMed Inc. · Last Guard Finance

DES

Key Statistics

Yahoo Finance

Performance

1 week: +5.27%
1 month: +7.48%
3 months: +18.19%
6 months: +1.88%
Year to date: −2.60%
1 year: −13.75%

Valuation & ownership

Market cap: 32.99B
Enterprise value: 33.20B
P/E (ttm): 22.49
Forward P/E: 17.73
PEG ratio: 1.33
Price / book: 5.14
Price / sales (ttm): 5.84
EV / EBITDA: 15.84
EPS (ttm): 10.43
EPS (forward): 13.23
Beta (5y monthly): 0.75
Dividend yield: 1.13%
Payout ratio: 23.01%
Shares outstanding: 140.64M
Float: 143.32M
Short % of float: 10.52%
Short ratio (days): 10.02
Held by insiders: 0.51%
Held by institutions: 72.93%
Avg volume (3m): 1.30M
50-day average: 225.66
200-day average: 225.15
52-week change: −13.75%
S&P 500 52-week: +17.50%

Technicals (daily)

RSI (14): 65.8
vs 50-day SMA: +3.96%
vs 200-day SMA: +4.20%
50 / 200-day trend: ▲ 50 above 200
MACD vs signal: ▲ above
ATR (14) % of price: 2.33%
Realised vol (20d, ann.): 19.3%
From 52-week high: −15.51%
From 52-week low: +30.14%

Signals (TECH)BREAKOUT GOLDEN X

ANR

Analyst Consensus

17 analysts

Consensus

Buy

2.30 on a 1 (strong buy) – 5 (sell) scale

Mean target

250.22

+6.66% implied

Low 175.00Median 235.00High 320.00

Recommendation trend

Now9 / 10 / 1
1m ago / 10 /

DES

About ResMed Inc.

Yahoo Finance profile

ResMed Inc. engages in the digital health and cloud-connected medical devices business in the United States and internationally. It operates in two segments, Sleep and Breathing Health, and Residential Care Software. The company offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry; and EasyCare Tx, a sleep lab solution. It also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; and connectivity module which provides a cellular connection between compatible ventilation devices and AirView system. In addition, the company offers Brightree solutions which are solutions and services for organizations in home medical equipment and pharmacy, orthotic and prosthetic, and home infusion; HEALTHCAREfirst solutions that offers electronic health record, software, billing and coding services, and advanced analytics that enables home health and hospice agencies to optimize clinical, financial and administrative processes; MatrixCare EHR software as a service solutions used by skilled nursing and senior living providers, life plan communities, and home health and hospice sectors; and MEDIFOX DAN software solutions that is used by residential care providers, such as home health and nursing home providers. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

Sector: Healthcare
Industry: Medical Instruments & Supplies
Employees: 11,370
Headquarters: San Diego, CA, United States

SEAS

Seasonality · RMD

2007–2026 · monthly returns

Strongest month Jul +4.89%Weakest month Sep −0.96%Averages use completed years only. Past seasonality doesn't predict future returns.

Year	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec	Year
2026	7.2	-0.8	-12.4	-4.8	-10.9	2.3	8.3	13.8	-7.9	6.1			−2.6%
2025	3.3	-1.1	-4.1	5.7	3.5	5.4	5.4	0.9	-0.3	-9.8	3.6	-5.8	+5.3%
2024	10.6	-8.7	14.0	8.1	-3.6	-7.2	11.4	14.9	-0.4	-0.7	2.7	-8.2	+32.9%
2023	9.7	-6.7	2.8	10.0	-12.5	3.7	1.8	-28.2	-7.3	-4.5	11.7	9.1	−17.3%
2022	-12.2	7.9	-1.7	-17.5	1.7	3.0	14.7	-8.6	-0.7	2.5	2.9	-9.6	−20.1%
2021	-5.2	-4.4	0.6	-3.1	9.5	19.8	10.3	6.9	-9.3	-0.2	-3.1	2.2	+22.5%
2020	2.6	-0.0	-7.3	5.5	3.5	19.4	5.5	-10.7	-5.2	12.0	9.2	1.4	+37.2%
2019	-16.4	7.6	1.5	0.5	9.2	6.9	5.5	8.2	-3.0	9.5	1.1	3.6	+36.1%
2018	19.0	-5.5	3.4	-3.9	8.6	0.7	2.1	5.3	3.5	-8.2	5.5	1.9	+34.5%
2017	8.8	6.6	-0.1	-5.5	4.6	9.5	-1.0	0.6	-0.8	9.4	1.4	-0.8	+36.5%
2016	5.6	0.4	1.6	-3.5	5.8	7.1	8.9	-3.2	-2.8	-7.7	2.9	0.9	+15.6%
2015	11.4	3.0	11.5	-10.9	-8.0	-4.2	2.8	-10.4	-1.9	13.0	3.4	-9.9	−4.2%
2014	-7.4	0.9	1.5	11.5	0.4	1.1	2.2	2.5	-7.1	6.0	1.9	5.4	+19.1%
2013	5.4	1.6	4.2	3.6	-0.0	-6.0	5.6	-0.9	11.8	-2.0	-5.7	-3.5	+13.3%
2012	14.3	0.9	5.5	10.0	-8.9	0.7	1.2	19.0	7.7	-1.3	2.9	1.2	+63.7%
2011	-9.1	0.3	-5.1	6.3	1.0	-3.9	-2.1	2.2	-7.0	-1.7	-8.0	-2.5	−26.7%
2010	-2.2	11.6	11.5	7.5	-8.1	-3.3	8.0	-8.2	8.9	-2.9	0.3	8.4	+32.5%
2009	6.5	-7.6	-4.2	8.8	-3.6	9.9	0.7	12.0	-1.5	8.9	2.2	4.0	+39.5%
2008	-11.6	-12.8	4.2	2.2	-8.7	-9.3	5.8	23.7	-8.1	-20.3	6.1	3.1	−28.7%
2007	6.8	-9.2	5.5	-16.1	6.7	-8.5	4.2	-5.4	5.4	-3.4	10.5	14.7	+6.7%

INSD

Insider Activity · RMD

Market-wide insider buying →Congress trades →SEC Form 4 filings via Yahoo Finance

Buys, 6 months

40.5K shares

Sells, 6 months

33K shares

Net shares

+7.5K

Net change in insider shares

+1.00%

Date	Insider	Transaction	Shares	Value
Oct 6, 2026	Farrell Michael J.Chief Executive Officer	Sale at price 226.33 per share.	5K	$1.13M
Oct 6, 2026	Farrell Michael J.Chief Executive Officer	Conversion of Exercise of derivative security at price 146.34 per share.	5K	$730.38K
Sep 7, 2026	Farrell Michael JChief Executive Officer	Sale at price 222.44 per share.	5K	$1.11M
Sep 7, 2026	Farrell Michael JChief Executive Officer	Conversion of Exercise of derivative security at price 146.34 per share.	5K	$730.38K
Aug 13, 2026	Leong JustinOfficer	Stock Award(Grant) at price 0.00 per share.	6.5K	—
Aug 13, 2026	Bloomer AaronChief Financial Officer	Stock Award(Grant) at price 0.00 per share.	9.1K	—
Aug 6, 2026	Farrell Michael JChief Executive Officer	Sale at price 205.69 per share.	5K	$1.03M
Aug 6, 2026	Farrell Michael JChief Executive Officer	Conversion of Exercise of derivative security at price 146.34 per share.	5K	$730.38K
Aug 4, 2026	Farrell Peter CraigDirector	Sale at price 225.00 per share.	8K	$1.80M
Jun 7, 2026	Farrell Michael JChief Executive Officer	Sale at price 193.96 per share.	5K	$968.06K
Jun 7, 2026	Farrell Michael JChief Executive Officer	Conversion of Exercise of derivative security at price 146.34 per share.	5K	$730.38K
May 6, 2026	Farrell Michael JChief Executive Officer	Sale at price 207.82 per share.	5K	$1.04M
May 6, 2026	Farrell Michael JChief Executive Officer	Conversion of Exercise of derivative security at price 146.34 per share.	5K	$730.38K
Apr 6, 2026	Farrell Michael JChief Executive Officer	Sale at price 225.50 per share.	5K	$1.13M
Apr 6, 2026	Farrell Michael JChief Executive Officer	Conversion of Exercise of derivative security at price 146.34 per share.	5K	$730.38K
Mar 31, 2026	Farrell Peter CraigDirector	Sale at price 225.00 per share.	2K	$450.00K
Mar 31, 2026	Sandercock BrettChief Financial Officer	Sale at price 224.31 per share.	1K	$224.31K
Mar 8, 2026	Farrell Michael JChief Executive Officer	Sale at price 251.03 per share.	5K	$1.25M
Mar 8, 2026	Farrell Michael JChief Executive Officer	Conversion of Exercise of derivative security at price 146.34 per share.	5K	$730.38K
Mar 3, 2026	Farrell Peter CraigDirector	Sale at price 260.22 per share.	2K	$520.44K

CONG

Congress Trades · RMD

House and Senate reports since 2025

Members

1 last bought

Buys

~$8.0K

Sells

~$56.0K

Net

−$48.0K

est. bought − sold

Latest

Mar 27, 26

Alan Armstrong

Members who traded it

Member	Buys	Sells	Est. net	Last move
Alan Armstrong Sen. OK	1		+$8.0K	Bought Mar 27, 26
Kelly Louise Morrison MN03		5	−$40.0K	Sold Jun 4, 25
Rob Bresnahan PA08		1	−$8.0K	Sold Jan 13, 25
Tommy Tuberville Sen. AL		1	−$8.0K	Sold May 3, 24

Bought and sold by quarter (est.)

Members of Congress's RMD trades, newest first
Traded	Member	Owner	Type	Amount	Filed	Report
Mar 27, 26	Alan Armstrong Sen. OK	Self	Buy	$1,001 - $15,000	Jul 21, 26 (116d)	Report
Jun 4, 25	Kelly Louise Morrison MN03	Self	Sell	$1,001 - $15,000	Jun 18, 25 (14d)	PDF
Jun 4, 25	Kelly Louise Morrison MN03	Self	Sell	$1,001 - $15,000	Jun 18, 25 (14d)	PDF
Jun 4, 25	Kelly Louise Morrison MN03	Self	Sell	$1,001 - $15,000	Jun 18, 25 (14d)	PDF
Jun 4, 25	Kelly Louise Morrison MN03	Self	Sell	$1,001 - $15,000	Jun 18, 25 (14d)	PDF
Apr 28, 25	Kelly Louise Morrison MN03	Self	Sell	$1,001 - $15,000	May 13, 25 (15d)	PDF
Jan 13, 25	Rob Bresnahan PA08	Joint	Sell	$1,001 - $15,000	Feb 13, 25 (31d)	PDF
May 3, 24	Tommy Tuberville Sen. AL	Joint	Sell	$1,001 - $15,000	Aug 5, 26 (824d)	Report

From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades

13F

Investors Holding RMD

latest 13F filings of 29 followed managers

Investors holding RMD
Investor	Value	Of portfolio	Shares	Change	Quarter
Bridgewater Associates · Ray Dalio	$13.1M	0.05%	67.38K	+72%	Q2 2026
Renaissance Technologies	$315.7K	0.00%	1.62K	New	Q2 2026

From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors

RMD

Price Chart

Keyboard shortcuts & functions

Anywhere

Command line

Charts (click the chart first)

Function codes

RMD

Price Chart

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

About ResMed Inc.

Seasonality · RMD

Insider Activity · RMD

Congress Trades · RMD

Members who traded it

Bought and sold by quarter (est.)

Investors Holding RMD

Investors Holding RMD

Congress Trades · RMD

Members who traded it

Bought and sold by quarter (est.)

Insider Activity · RMD

Seasonality · RMD

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

About ResMed Inc.

Financial Snapshot

Earnings & Dividends

News